FDA Inspection
AptaPharma Inc.AptaPharma Inc. – FDA Inspection, Mar 16, 2018
Record Details
This FDA Inspection record concerns AptaPharma Inc., with an inspection on March 16, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 56b08717-7de1-4c2d-9b87-592490ed7578
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1045668
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of AptaPharma Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 14, 2026 | VAI | New Jersey District Office | Drug Quality Assurance |
| October 24, 2024 | Not classified | New Jersey District Office | |
| May 15, 2023 | Not classified | New Jersey District Office | |
| September 25, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 23, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AptaPharma Inc.
- FDA Inspection 1331256 - 2026-08-14
- FDA Inspection 1231140 - 2024-10-24
- FDA Inspection 1205203 - 2023-05-15
- FDA Inspection 1102699 - 2019-09-25
- FDA Inspection 884304 - 2014-06-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.